390 related articles for article (PubMed ID: 30470382)
1. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
Winer KK; Kelly A; Johns A; Zhang B; Dowdy K; Kim L; Reynolds JC; Albert PS; Cutler GB
J Pediatr; 2018 Dec; 203():391-399.e1. PubMed ID: 30470382
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
Winer KK; Sinaii N; Reynolds J; Peterson D; Dowdy K; Cutler GB
J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
4. Therapy with PTH 1-34 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27 years at a single tertiary care center.
Winer KK; Ye S; Ferré EMN; Schmitt MM; Zhang B; Cutler GB; Lionakis MS
Bone; 2021 Aug; 149():115977. PubMed ID: 33932619
[TBL] [Abstract][Full Text] [Related]
5. Effect of parathyroid hormone administration in a patient with severe hypoparathyroidism caused by gain-of-function mutation of calcium-sensing receptor.
Shiohara M; Shiozawa R; Kurata K; Matsuura H; Arai F; Yasuda T; Koike K
Endocr J; 2006 Dec; 53(6):797-802. PubMed ID: 16983178
[TBL] [Abstract][Full Text] [Related]
6. Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.
Winer KK; Sinaii N; Peterson D; Sainz B; Cutler GB
J Clin Endocrinol Metab; 2008 Sep; 93(9):3389-95. PubMed ID: 18492754
[TBL] [Abstract][Full Text] [Related]
7. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
[TBL] [Abstract][Full Text] [Related]
8. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
[TBL] [Abstract][Full Text] [Related]
9. Advances in the treatment of hypoparathyroidism with PTH 1-34.
Winer KK
Bone; 2019 Mar; 120():535-541. PubMed ID: 30243992
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report.
Gonzales MC; Lieb DC; Richardson DW; O'Brian JT; Aloi JA; Khardori RK
Endocr Pract; 2013; 19(1):e24-8. PubMed ID: 23186954
[TBL] [Abstract][Full Text] [Related]
11. Therapy of hypoparathyroidism with intact parathyroid hormone.
Rubin MR; Sliney J; McMahon DJ; Silverberg SJ; Bilezikian JP
Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism.
Laurer E; Grünberger J; Naidoo U; Lanzersdorfer R; Wimleitner M; Tischlinger K; Högler W
Bone; 2021 Mar; 144():115834. PubMed ID: 33359892
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.
Winer KK; Ko CW; Reynolds JC; Dowdy K; Keil M; Peterson D; Gerber LH; McGarvey C; Cutler GB
J Clin Endocrinol Metab; 2003 Sep; 88(9):4214-20. PubMed ID: 12970289
[TBL] [Abstract][Full Text] [Related]
14. PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation.
Theman TA; Collins MT; Dempster DW; Zhou H; Reynolds JC; Brahim JS; Roschger P; Klaushofer K; Winer KK
J Bone Miner Res; 2009 May; 24(5):964-73. PubMed ID: 19063686
[TBL] [Abstract][Full Text] [Related]
15. Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety.
Tay YD; Tabacco G; Cusano NE; Williams J; Omeragic B; Majeed R; Gomez Almonte M; Bilezikian JP; Rubin MR
J Clin Endocrinol Metab; 2019 Nov; 104(11):5601-5610. PubMed ID: 31310310
[TBL] [Abstract][Full Text] [Related]
16. Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.
Winer KK; Zhang B; Shrader JA; Peterson D; Smith M; Albert PS; Cutler GB
J Clin Endocrinol Metab; 2012 Feb; 97(2):391-9. PubMed ID: 22090268
[TBL] [Abstract][Full Text] [Related]
17. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.
Winer KK; Yanovski JA; Cutler GB
JAMA; 1996 Aug; 276(8):631-6. PubMed ID: 8773636
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism.
Linglart A; Rothenbuhler A; Gueorgieva I; Lucchini P; Silve C; Bougnères P
J Clin Endocrinol Metab; 2011 Nov; 96(11):3308-12. PubMed ID: 21865375
[TBL] [Abstract][Full Text] [Related]
19. Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case series.
Bislev LS; Sikjaer T; Rejnmark L
Calcif Tissue Int; 2014 Oct; 95(4):374-81. PubMed ID: 25086672
[TBL] [Abstract][Full Text] [Related]
20. Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism.
Winer KK; Fulton KA; Albert PS; Cutler GB
J Pediatr; 2014 Sep; 165(3):556-63.e1. PubMed ID: 24948345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
